Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Short-Term Debt & Capital Lease Obligation : $588 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Hansoh Pharmaceutical Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $588 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Hansoh Pharmaceutical Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $15 Mil.

Hansoh Pharmaceutical Group Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Short-Term Debt & Capital Lease Obligation Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

0.52

1.69

1.57

2.23

588.12

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial									1.57	2.16	2.23	625.62	588.12

Hansoh Pharmaceutical Group Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Hansoh Pharmaceutical Group Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (OTCPK:HNSPF) » Definitions » Short-Term Debt & Capital Lease Obligation

Traded in Other Exchanges

03692:Hong Kong

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Headlines

No Headlines